Mirae Asset Global Investments
PFE icon

Mirae Asset Global Investments’s Pfizer PFE Stock Holding History

Mirae Asset Global Investments’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.1M Buy
1,539,905
+151,824
+11% +$3.97M 0.05% 203
2026
Q1 		$39M Buy
1,388,081
+242,360
+21% +$6.45M 0.01% 160
2025
Q4 		$28.5M Buy
1,145,721
+177,689
+18% +$4.48M 0.08% 207
2025
Q3 		$24.7M Buy
968,032
+124,138
+15% +$3.06M 0.08% 208
2025
Q2 		$20.5M Buy
843,894
+34,101
+4% +$795K 0.07% 222
2025
Q1 		$20.4M Sell
809,793
-3,097,889
-79% -$81.1M 0.08% 187
2024
Q4 		$104M Buy
3,907,682
+1,019,400
+35% +$27.7M 0.42% 38
2024
Q3 		$84M Buy
2,888,282
+659,906
+30% +$19.3M 0.37% 54
2024
Q2 		$61.9M Sell
2,228,376
-83,680
-4% -$2.3M 0.31% 64
2024
Q1 		$70.7M Buy
2,312,056
+742,583
+47% +$20.6M 0.15% 133
2023
Q4 		$45.2M Buy
1,569,473
+236,292
+18% +$7.14M 0.09% 212
2023
Q3 		$44.2M Buy
1,333,181
+109,087
+9% +$3.86M 0.1% 202
2023
Q2 		$44.9M Buy
1,224,094
+216,291
+21% +$8.42M 0.1% 208
2023
Q1 		$41.1M Buy
1,007,803
+69,648
+7% +$3.01M 0.1% 215
2022
Q4 		$48.1M Sell
938,155
-2,440
-0.3% -$117K 0.13% 191
2022
Q3 		$41.2M Buy
940,595
+33,428
+4% +$1.62M 0.11% 203
2022
Q2 		$47.6M Buy
907,167
+230,644
+34% +$11.8M 0.12% 190
2022
Q1 		$35M Sell
676,523
-255,094
-27% -$13.2M 0.07% 292
2021
Q4 		$55M Buy
931,617
+102,276
+12% +$5.07M 0.12% 194
2021
Q3 		$35.7M Buy
829,341
+51,826
+7% +$2.3M 0.09% 262
2021
Q2 		$30.4M Buy
777,515
+79,236
+11% +$3.08M 0.09% 295
2021
Q1 		$25.3M Buy
698,279
+298,672
+75% +$10.6M 0.09% 296
2020
Q4 		$14.7M Sell
399,607
-3,564
-0.9% -$131K 0.05% 391
2020
Q3 		$14M Buy
403,171
+38,367
+11% +$1.35M 0.07% 311
2020
Q2 		$11.3M Sell
364,804
-6,964
-2% -$237K 0.07% 308
2020
Q1 		$11.5M Sell
371,768
-7,992
-2% -$272K 0.09% 242
2019
Q4 		$14.1M Sell
379,760
-18,211
-5% -$649K 0.09% 274
2019
Q3 		$13.6M Buy
397,971
+50,604
+15% +$1.84M 0.09% 251
2019
Q2 		$14.3M Sell
347,367
-42,388
-11% -$1.68M 0.1% 231
2019
Q1 		$15.7M Sell
389,755
-379,064
-49% -$15.2M 0.11% 197
2018
Q4 		$31.8M Sell
768,819
-12,653
-2% -$525K 0.29% 74
2018
Q3 		$32.7M Buy
781,472
+376,115
+93% +$14.5M 0.24% 97
2018
Q2 		$14M Sell
405,357
-736,248
-64% -$25.2M 0.19% 87
2018
Q1 		$38.4M Buy
1,141,605
+113,322
+11% +$3.9M 0.5% 49
2017
Q4 		$35.3M Sell
1,028,283
-37,253
-3% -$1.27M 0.47% 42
2017
Q3 		$36.1M Sell
1,065,536
-42,821
-4% -$1.38M 0.66% 32
2017
Q2 		$35.3M Sell
1,108,357
-73,376
-6% -$2.31M 0.61% 38
2017
Q1 		$38.4M Sell
1,181,733
-115,459
-9% -$3.64M 0.72% 32
2016
Q4 		$40M Sell
1,297,192
-70,374
-5% -$2.15M 0.89% 25
2016
Q3 		$43.9M Sell
1,367,566
-69,970
-5% -$2.34M 0.91% 33
2016
Q2 		$48M Sell
1,437,536
-321,886
-18% -$10.3M 1.24% 14
2016
Q1 		$49.5M Buy
1,759,422
+95,267
+6% +$2.72M 1.34% 15
2015
Q4 		$51M Buy
1,664,155
+83,928
+5% +$2.64M 1.68% 10
2015
Q3 		$47.1M Sell
1,580,227
-201,077
-11% -$6.45M 1.93% 8
2015
Q2 		$56.7M Buy
1,781,304
+271,655
+18% +$8.85M 1.82% 10
2015
Q1 		$49.8M Sell
1,509,649
-55,135
-4% -$1.75M 1.69% 11
2014
Q4 		$46.2M Buy
1,564,784
+638,234
+69% +$18.3M 1.68% 16
2014
Q3 		$26M Buy
926,550
+210,052
+29% +$5.9M 0.94% 35
2014
Q2 		$20.2M Buy
716,498
+536,633
+298% +$15.3M 0.45% 50
2014
Q1 		$5.48M Buy
179,865
+6,830
+4% +$204K 0.14% 56
2013
Q4 		$5.03M Buy
173,035
+69,653
+67% +$2.03M 0.21% 67
2013
Q3 		$2.82M Sell
103,382
-14,094
-12% -$383K 0.13% 97
2013
Q2 		$3.12M Buy
+117,476
New +$3.25M 0.17% 80

Other funds holding PFE

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Mirae Asset Global Investments's PFE Position: Q2 2026 in Review

Mirae Asset Global Investments increased its Pfizer (PFE) stake by 11% in Q2 2026, buying an estimated $3.97M and bringing the position to 1,539,905 shares worth $37.1M. The position accounts for 0.05% of the portfolio, ranked #203.

Mirae Asset Global Investments first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $104M in Q4 2024. 1,369 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Mirae Asset Global Investments held 1,539,905 shares of Pfizer worth $37.1M as of Q2 2026.
  • Mirae Asset Global Investments bought 151,824 Pfizer shares in Q2 2026, an estimated $3.97M.
  • Pfizer made up 0.05% of Mirae Asset Global Investments's portfolio in Q2 2026, its #203 holding.
  • Mirae Asset Global Investments first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Mirae Asset Global Investments's Pfizer position peaked at $104M in Q4 2024.
  • 1,369 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.